Trichostatin-A (TSA), a histone deacetylase (HDAC) inhibitor, results in enhanced acetylation of core histones thereby disrupting chromatin organization within living cells. We report on changes in chromatin organization and the resultant alteration in nuclear architecture following treatment with TSA using fluorescence imaging. TSA triggers an expected increase in the euchromatin fraction which is accompanied by a significant increase in nuclear volume and alterations in chromatin compaction mapped using fluorescence anisotropy imaging. We observe differential changes in the mobility of core and linker histones as measured by fluorescence recovery after photo-bleaching (FRAP) and fluorescence correlation spectroscopy (FCS) methods. Further...
[[abstract]]The epigenetic modulation by histone deacetylase (HDAC) inhibitors including trichostati...
AbstractHistone deacetylase (HDAC) inhibitors are being developed as new clinical agents in cancer t...
Histone deacetylase inhibitors (HDACi) are a class of putative chemotherapeutic agents for which the...
The effect of trichostatin A (TSA)-induced histone acetylation on the interphase chromatin structure...
Valproic acid (VPA) and trichostatin A (TSA) are known histone deacetylase inhibitors (HDACIs) with ...
Trichostatin A (TSA), an inhibitor of histone deacetylase (HDAC), is widely used to study the role o...
Trichostatin A, a histone deacetylase inhibitor, could increase histone acetylation, and active gene...
Posttranslational modifications of histones in chromatin are emerging as an important mechanism in t...
<p>A) Western blot analysis of cytosolic fractions of MCF-7 cells treated with indicated concentrati...
A nucleosome is made up of DNA and histones, and acetylation of histones perturbs the interaction of...
AbstractHistone acetylation may act to mark and maintain transcriptionally active or inactive chromo...
<div><p>Actin plays a role in various processes in eukaryotic cells, including cell growth and death...
Histone deacetylase inhibitors (HDACi) are promising antitumor drugs acting through reactivation of ...
The epigenetic modulation by histone deacetylase (HDAC) inhibitors including trichostatin A (TSA) ha...
[[abstract]]The epigenetic modulation by histone deacetylase (HDAC) inhibitors including trichostati...
[[abstract]]The epigenetic modulation by histone deacetylase (HDAC) inhibitors including trichostati...
AbstractHistone deacetylase (HDAC) inhibitors are being developed as new clinical agents in cancer t...
Histone deacetylase inhibitors (HDACi) are a class of putative chemotherapeutic agents for which the...
The effect of trichostatin A (TSA)-induced histone acetylation on the interphase chromatin structure...
Valproic acid (VPA) and trichostatin A (TSA) are known histone deacetylase inhibitors (HDACIs) with ...
Trichostatin A (TSA), an inhibitor of histone deacetylase (HDAC), is widely used to study the role o...
Trichostatin A, a histone deacetylase inhibitor, could increase histone acetylation, and active gene...
Posttranslational modifications of histones in chromatin are emerging as an important mechanism in t...
<p>A) Western blot analysis of cytosolic fractions of MCF-7 cells treated with indicated concentrati...
A nucleosome is made up of DNA and histones, and acetylation of histones perturbs the interaction of...
AbstractHistone acetylation may act to mark and maintain transcriptionally active or inactive chromo...
<div><p>Actin plays a role in various processes in eukaryotic cells, including cell growth and death...
Histone deacetylase inhibitors (HDACi) are promising antitumor drugs acting through reactivation of ...
The epigenetic modulation by histone deacetylase (HDAC) inhibitors including trichostatin A (TSA) ha...
[[abstract]]The epigenetic modulation by histone deacetylase (HDAC) inhibitors including trichostati...
[[abstract]]The epigenetic modulation by histone deacetylase (HDAC) inhibitors including trichostati...
AbstractHistone deacetylase (HDAC) inhibitors are being developed as new clinical agents in cancer t...
Histone deacetylase inhibitors (HDACi) are a class of putative chemotherapeutic agents for which the...